Zoetis (ZTS) Stock Price & AI Analysis

$161.44
-$2.21
(1.35%)
Pharmaceuticals

NYSE USA

May 22, 3:07 PM EDT
  • Market Cap.
    71.87B
  • Volume
    2.92M
  • Avg. Volume
    2.94M
  • Target Price
    $200.29
  • 52W Range
    139.70 - 200.33
  • RSI (14)
    54.56
  • Beta
    0.93
  • PEG Ratio
    3.45
  • SMA 20
    2.22%
  • SMA 50
    2.63%
  • SMA 200
    -6.45%
  • Insider Owner
    0.1%
  • Insider Trans
    -1.27%
  • Institution Owner
    95.92%
  • Institution Trans
    1.74%
  • Short Interest
    9.33%
  • EPS next Y
    10.11

Zoetis Company Profile

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Zoetis | Latest news

ZTS Q1 Earnings Call: Guidance Raised as Platform Products Drive Momentum Amid...

Animal health company Zoetis (NYSE:ZTS) reported Q1 CY2025 results topping the market’s revenue...

StockStory - 3 days ago

Decoding Zoetis Inc (ZTS): A Strategic SWOT Insight

Comprehensive SWOT analysis of Zoetis Inc, highlighting key strengths such as market leadership and diversified product portfolio. Identification of...

GuruFocuscom - 1 year ago

Is Zoetis Inc. (ZTS) The Best Pet Stock To Invest In According To Analysts?

We recently compiled a list of the 10 Best Pet Stocks To Invest In According to Analysts. In this...

Insider Monkey - 6 months ago

Zoetis' (ZTS) Companion Animal Products to Boost Revenues

Zoetis' (ZTS) revenues are expected to boost the pet care and livestock product sales in the...

Zacks - 2 years ago

Zoetis Inc. (ZTS): Did this Feminist Stock Soar High in Q1?

We recently compiled a list of the 11 Best Feminist Stocks To Invest In. In this article, we are...

Insider Monkey - 11 months ago

Zoetis (NYSE:ZTS) Posts Q4 Sales In Line With Estimates But Stock Drops

Animal health company Zoetis (NYSE:ZTS) met Wall Street’s revenue expectations in Q4 CY2024, with...

StockStory - 3 months ago

Zoetis Inc. (ZTS): A Bull Case Theory

We came across a bullish thesis on Zoetis Inc. (NYSE:ZTS) on Substack by Best Anchor Stocks. In this article, we will summarize the bulls’ thesis on ZTS....

Insider Monkey - 5 months ago

Jim Cramer Likes Zoetis Inc (NYSE:ZTS) “Very Much”

We recently published a list of Jim Cramer Stock Portfolio for Q4: Top 11 Stocks to Buy and Sell. Since Zoetis Inc (NYSE:ZTS) ranks 4th on the list, it...

Insider Monkey - 8 months ago

Zoetis’s (NYSE:ZTS) Q1: Beats On Revenue, Full-Year Sales Guidance is Optimistic

Animal health company Zoetis (NYSE:ZTS) reported Q1 CY2025 results topping the market’s revenue...

StockStory - 2 weeks ago

Is Zoetis Inc (ZTS) Modestly Undervalued? A Comprehensive Valuation Analysis

Zoetis Inc (NYSE:ZTS) recently recorded a daily gain of 2.67%, and a 3-month gain of 0.81%. With an...

GuruFocuscom - 2 years ago